GovChime
IDVSmall business

IDC (multiple-award IDV) HHSN271201700012ICATALENT MARYLAND, INC.

Overview

Award facts

Orders under this IDV
No orders recorded under this IDV.
Period of performance
From Mar 31, 2017
Modifications
1
Latest action Jan 21, 2022
Contract type
IDC (multiple-award IDV)
PIID HHSN271201700012I

Description of requirement

IGF::OT::IGF PARENT IDIQ AWARD: CRO SUPPORT FOR NCATS DRUG SUBSTANCE DEVELOPMENT AND MANUFACTURE

Dates and value

Award date
Signed on Mar 31, 2017
Ordering period ends
Jan 21, 2022

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 21, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationBALTIMORE, MD
UEIUBMBZUF5VMV4
CAGE code3HTH0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCATALENT, INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NCATS
Funded from
National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)

Classification and competition

Classification

Product or service (PSC)
AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
Offers received
10

Solicitation and notices

Solicitation ID
N01TR172001(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
Cro support for ncats drug substance development and manufacture
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Mar 31, 2017Base obligation at award: $5,000
Latest action
Jan 21, 2022 — Terminated for convenienceModification P00001; obligation change -$5,000
Latest substantive action
Jan 21, 2022 — Terminated for convenienceModification P00001; obligation change -$5,000
Actions by type
  • Base award1
  • Terminated for convenience1
2 actions recorded, Mar 31, 2017 to Jan 21, 2022; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Latest action: change in base and all options
-$24,598,861

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / indefinite quantityB
Multiple or single award
Multiple awardM
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N95C
Treasury accounts
  • 075-2017/2017-0875-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression